Original Synthesis of Substituted 6H-Benzo[c]chromene Derivatives Using a TDAE and Pd-Catalyzed Cyclization Strategy
Donia Ben Salah, Omar Khoumeri, Theo-Bob Muller, Naceur Hamdi, Thierry Terme, Patrice Vanelle

TL;DR
A new method was developed to efficiently synthesize 6H-benzo[c]chromene derivatives using a two-step process involving TDAE and palladium catalysis.
Contribution
The paper introduces a novel synthetic strategy combining TDAE and Pd-catalyzed cyclization for substituted 6H-benzo[c]chromene derivatives.
Findings
A TDAE-initiated reaction successfully produced substituted 1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-phenylethanols.
Palladium-catalyzed intramolecular O-arylation under microwave irradiation completed the synthesis of 6H-benzo[c]chromene derivatives.
X-ray crystallography confirmed the structure of one of the synthesized derivatives (product 5c).
Abstract
We report an efficient synthetic method for the preparation of 6H-benzo[c]chromenes from substituted 1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-phenylethanols. These intermediates were obtained via a TDAE-initiated reaction between new substituted 2′-bromo-[1,1′-biphenyl]-2-carbaldehyde derivatives and substituted nitrobenzylic chlorides. The second step involved a palladium-catalyzed intramolecular O-arylation of the alcohol intermediate under microwave irradiation (110 °C for 1.5 h). The structure of 6H-benzo[c]chromene derivatives was confirmed by X-ray crystallography of product 5c.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSynthesis of Organic Compounds · Catalytic Cross-Coupling Reactions · Catalytic C–H Functionalization Methods
1. Introduction
Tetrakis(dimethylamino)ethylene (TDAE) is a reducing agent that reacts under mild conditions with activated halogenated derivatives to generate an anion via two sequential single electron transfers [1,2,3,4,5,6,7,8,9,10,11]. The first SET generates the radical and the second SET forms the anion. The carbanion generated by TDAE from o- or p-nitrobenzyl chloride can react with various electrophiles, such as aromatic aldehydes, ketones, α-keto esters, α-keto lactams, and diethyl oxomalonate, yielding the corresponding secondary alcohol [12,13,14]. Polycycles are fundamental scaffolds in organic compounds and are widely found in natural products, bioactive molecules, and synthetic drugs [15]. Their synthesis has been widely studied. Among these, fused heterocyclic compounds are of great importance and are broadly applied in different aspects [16]. Among the most important fused heterocycles found in several natural products, fused oxygen-containing heterocycles exhibit a wide range of biological activities. Among these compounds, cannabinol and its derivatives can be mentioned [17,18,19,20,21,22]. Many research groups have synthesized these compounds. Fagnou and co-workers have developed the synthesis via direct arylation [23,24,25,26], whereas Shen’s synthesis involves the use of palladium-catalyzed intramolecular decarboxylative coupling of arene carboxylic acids/esters with aryl bromides [27]. Shi and co-workers used transition metal-catalyzed direct functionalization of aromatic C–H bonds [28]. Herein, we report a new efficient synthesis of 6H-benzo[c]chromenes. Our strategy involves the activation of the alcohol using Cs_2_CO_3_ to generate alkoxide, followed by a Pd-catalyzed intramolecular C–O coupling of 1-(2′-bromo-[1,1′-biaryl]-2-yl)-2-(aryl)ethan-1-ol under microwave irradiation. The 1-(2′-bromo-[1,1′-biaryl]-2-yl)-2-(aryl)ethan-1-ols were obtained through the TDAE-mediated strategy using 2′-bromo-biaryl-2-carbaldehydes as electrophiles and nitrobenzyl chlorides, which serve as anion precursors, in moderate-to-good yields. The TDAE strategy offers the advantage of generating a nitrobenzyl carbanion under mild and practical conditions.
2. Results and Discussion
The starting materials 1a–i for the TDAE reactions were prepared by Suzuki–Miyaura cross-coupling [29,30] by the treatment of 2-bromocarboxaldehydes (1 equiv) with 2-bromophenylboronic acid (1.3 equiv) in the presence of Pd(PPh_3_)4 (0.0161 equiv) and Na_2_CO_3_ (3.9 equiv in 10 mL of H_2_O) in toluene at 90 °C for 12 h (Scheme 1). After chromatographic separation, the desired 2′-bromo-biaryl-2-carbaldehydes 1a–i were isolated in moderate-to-good yields (48–87%).
The reaction of 2′-bromo-biaryl-2-carbaldehydes 1a–i (1 equiv) with activated benzylic halides such as 4-nitrobenzyl chloride 2a (1.3 equiv) under inert atmosphere (N_2_), in anhydrous DMF in the presence of TDAE at −20 °C for one hour, followed by 2 h at room temperature, led to the corresponding alcohol products 3a–i in moderate-to-good yields (49–84%), as shown in Scheme 2 and Table 1.
We therefore extended this reaction to other nitrobenzyl chlorides 2b–k, which were either commercially available (2a,b) or prepared (2c–k) as shown in Scheme 3. Nitrobenzylic chlorides 2c–k were prepared in two steps from the corresponding aldehydes by the reduction of the aldehyde, followed by chlorination of the resulting alcohol. The corresponding nitrobenzylic chlorides 2c–k were isolated in good-to-excellent yields (70–92%).
These substituted benzyl chlorides 2b–k reacted with 2′-bromo-[1,1′-biphenyl]-2-carbaldehyde 1a under the usual conditions, 2′-bromo-[1,1′-biphenyl]-2-carbaldehyde (1a; 1 equiv) with substituted benzyl chlorides (2b–k; 1.3 equiv) in anhydrous DMF in the presence of TDAE at −20 °C for one hour, followed by 2 h at room temperature, yielding the corresponding alcohol 4b–k in good yields (64–93%), as shown in Scheme 4 and Table 2.
The reaction of 2′-bromo-biaryl-2-carbaldehydes 1 with nitrobenzylic chlorides 2b–k led to a mixture of two isomers, easily separable by column chromatography. The first fraction corresponded to products with the Br and OH group “cis-substituted”, while the second fraction contained products with the Br and OH group “trans-substituted”, as shown in Scheme 5. However, evaporation of each separate fraction under reduced pressure at 40 °C resulted in the same mixture of the two isomers. This demonstrates the interconversion of the two isomers under the effect of heat during evaporation.
Compound 3a was used as the model substrate for synthesis of 6H-benzo[c]chromene 5. We investigated the influence of such parameters as the solvents (DMF, CH_3_CN, or dioxane), the Pd-catalyst (Pd(PPh_3_)2_Cl_2, Pd(OAc)2 or Pd(PPh_3_)4), the ligand (PPh_3_ or BINAP), the type and the amount of the base (2, 3, or 4 equiv) and the reaction time and temperature (Table 3). The first tests (Table 3, entries 1–4) carried out with standard solvents and bases for this method led us to choose toluene as the optimal solvent and Cs_2_CO_3_ as the best base (Table 3, entry 4). Then, we applied the reaction conditions with different catalysts (Pd(PPh_3_)2_Cl_2, Pd(OAc)2, Pd(PPh_3_)4), in the presence or the absence of ligand (PPh_3_, BINAP) and different amounts of the base (Cs_2_CO_3_). An excess of base is necessary to deprotonate the alcohol forming the alkoxide, which then undergoes coupling. The best yield (87%) of 6-(4-nitrobenzyl)-6H-benzo[c]chromene (5a) was obtained with Pd(OAc)2, PPh_3_ as supporting ligand, and 3 equivalents of Cs_2_CO_3_ at 110 °C for 5 h (Table 3, entry 8). After optimizing the reaction conditions with a reaction time of 5 h, we wanted to determine whether we could carry out the reaction in a shorter time under microwave irradiation. We therefore reduced the reaction time to 1 h and then extended it to 1.5 h and 2 h (Table 3, entries 10–12). A similar best yield of 5a (88% vs. 87%) was obtained when the reaction was heated at 110 °C under microwave irradiation for only 1.5 h (Table 3, entry 11).
After optimization of the conditions (Table 3, entry 11), we generalized the cyclization with different alcohol derivatives. The corresponding 6H-benzo[c]chromenes 5a–s were obtained in moderate-to-good yields (37–91%, Table 4). The optimal reaction time is 1.5 h (88% yield), as the yield is lower at 1 h (75%, incomplete reaction) and decreases to 79% at 2 h (product degradation).
It is quite difficult to establish clear relationships between the nature of the substituents (at R^1^ and R^2^) and the obtained yields, as there are many parameters involved (substituent position, stability and solubility of the final product). The only noticeable effect is that when R^1^ is a halogen (Cl, F) or a nitro group, the yield is very high (77–91%).
The structure of product 5c was confirmed by X-ray crystallography, and an ORTEP view is reported in Figure 1 [31]. Crystal data for C_21_H_17_NO_3_ (M = 331.36 g/mol): monoclinic, space group P2_1_/c (no. 14), a = 17.0030(19) Å, b = 10.1693(11) Å, c = 9.6214(12) Å, β = 92.347(10)°, V = 1662.2 (3) Å^3^, Z = 4, T = 295 K, μ(Mo Kα) = 0.089 mm^−1^, Dcalc = 1.324 g/cm^3^, 11,226 reflections measured (7.196° ≤ 2Θ ≤ 59.016°), 3896 unique (Rint = 0.0615, Rsigma = 0.0883), which were used in all calculations. The final R1 was 0.0667 (I > 2σ(I)), and wR2 was 0.1731 (all data).
3. Materials and Methods
3.1. General Chemistry Information
TDAE is commercially available. All melting points were determined on a Stuart melting point apparatus SMP3, and are uncorrected. The ^1^H-NMR spectra were recorded on a Bruker Avance III spectrometer operating at 400 MHz (^1^H) or 100 MHz (^13^C) (Bruker, Billerica, MA, USA). ^1^H- and ^13^C-NMR chemical shifts were reported in parts per million (ppm) and were referenced to the residual proton peaks in a deuterated solvent, CDCl_3_ (7.26 ppm for ^1^H and 77.16 ppm for ^13^C). Multiplicities are represented by s (singlet), d (doublet), t (triplet), q (quartet), dd (doublet of doublet), dt (doublet of triplets), and m (multiplet). TLC was performed on 5 cm × 10 cm aluminum plates coated with silica gel 60F-254 (Merck) in an appropriate eluent. HRMS was performed out at the Spectropole, Faculte des Sciences et Techniques de Saint-Jérôme, Marseille. HRMS spectra were recorded on a SYNAPT G2 HDMS mass spectrometer (Waters, Milford, MA, USA) equipped with an electrospray ionization (ESI) source. All anhydrous solvents used were purchased commercially and used without further purification. Microwave reactions were performed with a Biotage^®^ Initiator Microwave oven (Uppsala, Sweden) using 10–20 mL sealed vials; temperatures were measured with an IR sensor, and reaction times are given as hold times. Column chromatography was performed with puriFlash^®^ 5.020 (Advion, Interchim Scientific, Montluçon, France) (solid injection mode, column (IR-20SI-F0012), 3 racks, 132 test tubes (18 × 150 mm). Single-crystal X-ray diffraction data were collected on a SuperNova, Dual, Cu at home/near, AtlasS2 diffractometer (Rigaku Oxford Diffraction, Tokyo, Japan). All commercial reagents were used without purification.
3.2. General Procedure for the Synthesis of 2′-Bromo-biaryl-2-carbaldehydes (1a–i)
A vial was charged with Pd(PPh_3_)4 (0.0161 equiv), (2-bromophenyl)boronic acid (1.4 equiv), and 2-bromocarboxaldehydes (1 equiv). The test tube was sealed with a cap lined with a disposable silicone septum, evacuated, and purged with N_2_ (×3). To the vial were added toluene (10 mL) and a solution of Na_2_CO_3_ (3.9 equiv) in 10 mL of water. The test tube was evacuated and purged with N_2_ (×3) a second time; then the reaction was heated at 90 °C for 12 h. The reaction mixture was allowed to cool to room temperature, then transferred to a separatory funnel. The layers were separated, and the organic layer was extracted with ethyl acetate and washed with brine, dried over anhydrous sodium sulfate, and filtered, and then the solvent was removed under reduced pressure. The resulting oil was purified by silica gel column chromatography (elution with petroleum ether/dichloromethane: 5/5).
2′-bromo-[1,1′-biphenyl]-2-carbaldehyde (1a). Yield: 48%; Mp: 80 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 7.28–7.34 (m, 3H, H_arom_), 7.40–7.44 (m, 1H, H_arom_), 7.53–7.57 (m, 1H, H_arom_), 7.64–7.71 (m, 2H, H_arom_), 8.04 (dd, J = 7.80, 1.4 Hz, 1H, H_arom_), 9.79 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 123.98 (C_6_), 127.50 (C_2′), 127.53 (C_3), 128.70 (C_4_), 129.94 (C_5_), 130.96 (C_4′), 131.72 (C_5′), 132.90 (C_3′), 133.78 (C_1), 133.82 (C_5_), 139.01 (C_1′), 144.61 (C_2), 191.66 (CHO). HRMS (ESI): m/z [M+Na]^+^ calcd for C_13_H_9_BrO: 282.9729; found: 282.9728.
2′-bromo-4-methoxy-[1,1′-biphenyl]-2-carbaldehyde (1b). Yield: 73%; Mp: oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.90 (s, 3H, H_arom_), 7.19–7.23 (m, 2H, H_arom_), 7.28–7.32 (m, 2H, H_arom_), 7.40 (td, J = 7.40, 1.30 Hz, 1H, H_arom_), 7.52 (dd, J = 2.6, 0.6 Hz, 1H, H_arom_), 7.68 (dd, J = 8.00, 1.20 Hz, 1H, H_arom_), 9.74 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 55.72 (C_b_), 109.92 (C_3_), 121.28 (C_5_), 124.59 (C_2′), 127.48 (C_1), 129.78 (C_5′), 132.13 (C_6), 132.22 (C_4′), 132.87 (C_6′), 134.71 (C_3′), 137.64 (C_1′), 138.68 (C_2_), 159.73 (C_4_), 191.52 (CHO). HRMS (ESI): m/z [M+H]^+^ calcd for C_14_H_11_BrO_2_: 290.0015; found: 291.0011.
2′-bromo-5-methyl-[1,1′-biphenyl]-2-carbaldehyde (1c). Yield: 57%; Mp: oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.46 (s, 3H, H_arom_), 7.11 (d, J = 7.11 Hz, 1H, H_arom_), 7.29–7.42 (m, 4H, H_arom_), 7.68 (dd, J = 7.68 Hz, 1H, H_arom_), 7.94 (d, J = 7.94 Hz, 1H, H_arom_), 9.73 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 21.96 (C_b_), 123.95 (C_2′), 127.45 (C_5), 127.60 (C_4_), 129.53 (C_4′), 129.80 (C_3), 131.45 (C_6′), 131.53 (C_3′), 131.64 (C_1_), 132.80 (C_1′), 139.20 (C_2), 144.68 (C_6_), 144.85 (C_5_), 191.33 (CHO). HRMS (ESI): m/z [M+H]^+^ calcd for C_14_H_11_BrO: 275.0066; found: 275.0072.
6-(2′-bromophenyl)benzo[d][1,3]dioxole-5-carbaldehyde (1d). Yield: 65%; Mp: 93 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 6.11 (s, 2H, CH_2_), 6.72 (s, 1H, H_arom_), 7.27–7.31 (m, 2H, H_arom_), 7.37–7.41 (m, 1H, H_arom_), 7.46 (s, 1H, H_arom_), 7.67 (d, J = 7.67 Hz, 1H, H_arom_), 9.53 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 102.38 (C_2_), 106.10 (C_7_), 110.55 (C_4_), 124.28 (C_2′), 127.43 (C_1), 129.01 (C_5′), 130.00 (C_4′), 131.95 (C_6′), 132.95 (C_3′), 138.55 (C_5_), 141.98 (C_1′), 148.37 (C_3a), 152.24 (C_7a_), 189.89 (CHO). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_14_H_9_BrO_3_: 304.9808; found: 304.9810.
2′-bromo-5-methoxy-[1,1′-biphenyl]-2-carbaldehyde (1e). Yield: 68%; Mp: 92 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.90 (s, 3H, CH_3_), 6.77 (d, J = 6.77 Hz, 1H, H_arom_), 7.04 (ddd, J = 8.70, 2.61, 0.80 Hz, 1H, H_arom_), 7.28–7.34 (m, 2H, H_arom_), 7.41 (m, 1H, H_arom_), 7.68 (dd, J = 8.00, 0.90 Hz, 1H, H_arom_), 8.02 (d, J = 8.02 Hz, 1H, H_arom_), 9.63 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 55.79 (C_b_), 114.54 (C_4_), 115.68 (C_6_), 123.76 (C_2′), 127.41 (C_5′), 127.43 (C_4′), 129.89 (C_6′), 129.92 (C_3_), 131.51 (C_5_), 132.86 (C_2_), 138.96 (C_1_), 146.93 (C_1′), 163.75 (C_5), 190.29 (CHO). HRMS (ESI): m/z [M+H]^+^ calcd for C_14_H_11_BrO_2_: 291.0015; found: 291.0019.
2′-bromo-5-chloro-[1,1′-biphenyl]-2-carbaldehyde (1f). Yield: 72%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 7.31–7.35 (m, 3H, H_arom_), 7.46 (td, J = 8.40, 1.3, Hz, 1H, H_arom_), 7.52 (ddd, J = 8.40, 2.0, 0.80 Hz, 1H, H_arom_), 7.69–7.71 (m, 1H, H_arom_), 7.98 (d, J = 7.98 Hz, 1H, H_arom_), 9.72 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 123.72 (C_2′), 127.69 (C_6), 128.96 (C_4_), 129.10 (C_5′), 130.40 (C_4′), 130.96 (C_6′), 131.53 (C_3′), 132.20 (C_3_), 133.02 (C_1′), 137.60 (C_1), 140.11 (C_2_), 145.86 (C_5_), 190.33 (CHO). HRMS (ESI): m/z [M+H]^+^ calcd for C_13_H_8_BrClO: 296.9; found: 296.9500.
2′-bromo-4-fluoro-[1,1′-biphenyl]-2-carbaldehyde (1g). Yield: 75%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 7.30–7.44 (m, 5H, H_arom_), 7.69–7.72 (m, 2H, H_arom_), 9.72 (d, J = 9.71 Hz, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) 113.61 (d, J = 22.50 Hz, C_3_), 120.98 (d, J = 22.00 Hz, C_5_), 124.18 (C_2′), 127.64 (C_5′), 130.20 (C_4′), 131.89 (C_3′), 132.94 (d, J = 8.07, C_6_), 132.99 C_6′), 135.52 (d, J = 6.50 Hz,C_2), 137.91 (C_1′), 140.58 (d, J = 3.50 Hz, C_1), 162.66 (d, J = 240.94 (C_4_), 190.34 (d, J = 2.10 Hz, CHO). HRMS (ESI): m/z [M+H]^+^ calcd for C_13_H_8_BrFO: 277.0; found: 276.9673.
2′-bromo-4-nitro-[1,1′-biphenyl]-2-carbaldehyde (1h). Yield: 78%; Mp: 85 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 7.33 (dd, J = 7.52, 1.77 Hz, 1H, H_5′), 7.39 (td, J = 7.52, 1.77 Hz, 1H, H_4′) 7.49 (td, J = 7.52, 1.2 Hz, 1H, H_6′), 7.55 (d, J = 8.40 Hz, 1H, H_6), 7.74 (dd, J = 8.03, 1.26 Hz, 1H, H_3′), 8.48 (dd, J = 8.40, 2.46 Hz, 1H, H_5), 8.84 (d, J = 2.46 Hz, 1H, H_3_), 9.79 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) =116.15 (C_4_), 117.94 (C_6_), 123.58 (C_2′), 127.63 (C_5′), 130.35 (C_4′), 130.44 (C_6′), 131.45 (C_1′), 133.01 (C_3′), 137.71 (C_3_), 147.21 (C_1_), 164.34 (C_2_), 166.90 (C_5_), 189.93 (CHO). HRMS (ESI): m/z [M+H]^+^ calcd for C_13_H_8_BrNO_3_: 303.9615; found: 303.9614.
2′-bromo-5-fluoro-[1,1′-biphenyl]-2-carbaldehyde (1i). Yield: 87%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 7.02 (dd, J = 7.02 Hz, 1H, H_arom_), 7.23 (td, J = 8.20, 2.51 Hz, 1H, H_arom_), 7.31–7.35 (m, 2H, H_arom_), 7.42 (td, J = 7.43, 1.61 Hz, 1H, H_arom_), 7.70 (d, J = 8.20 Hz, 1H, H_arom_), 8.07 (dd, J = 8.07, 2.51 Hz, 1H, H_arom_), 9.69 (s, 1H, CHO); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 116.15 (d, J = 21.8 Hz (C_4_), 117.95 (d, J = 22.13 Hz) (C_6_), 123.58 (C_2′), 127.63 (C_5′), 130.35 (C_4′), 130.44(d, J = 9.23 Hz) (C_3), 130.47 (C_1′), 131.45 (C_6′), 133.01 (C_3′), 137.71(d, J = 1.96 Hz) (C_2), 147.16(d, J = 9.47 Hz) (C_1_), 164.65 (d, J = 257.18 Hz) (C_5_), 189.93 (CHO). HRMS (ESI): m/z [M+H]^+^ calcd for C_13_H_8_BrFO: 278.9815; found: 278.9813.
3.3. General Procedure for the Synthesis of 1-(2′-Bromo-[1,1′-biaryl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3a–i)
To a 100 mL round-bottom flask equipped with a magnetic stir bar, a rubber septum, and a nitrogen inlet, containing 2′-bromo-biaryl-2-carbaldehydes (300 mg, 1 equiv), 10 mL of anhydrous DMF was added. The solution was stirred at −20 °C for 10 min; then TDAE (1.3 equiv) was added. To the round-bottom flask, 10 mL of anhydrous DMF solution of 4-nitrobenzyl chloride (1.3 equiv) was added dropwise with a syringe. A red color immediately developed, with the formation of a fine white precipitate (octamethyloxamidinium dichloride, TDAECl_2_). The mixture was stirred at −20 °C for 1 h, then warmed to room temperature over 2 h. Then water was added to quench the reaction. The solution was extracted with ethyl acetate (3 × 30 mL), and the combined organic layers were washed with brine (3 × 50 mL), and dried over Na_2_SO_4_. The crude product was then obtained after evaporation of the solvent under reduced pressure. Purification by silica gel chromatography (dichloromethane/cyclohexane: 7/3) yielded the corresponding compounds 3a–i as “cis-substituted” and “trans-substituted” forms.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3a). Yield: 84%; Mp: 101 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.87–3.13 (m, 2H, CH_2_), 4.69–4.79 (m, 1H, CH), 6.77–7.75 (m, 10H, H_arom_), 8.07 (d, J = 8.71 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.15/44.89 (C_2_), 71.63/72.14 (C_1_), 123.45/123.67 (C_3″), 123.57/124.07 (C_5″), 125.63/125.79 (C_2′), 127.55/127.58 (C_3), 127.62 (C_6_), 128.03 (C_5_), 128.78/128.97 (C_4_), 129.28/129.53 (C_5′), 129.34/130.25 (C_4′), 130.34/130.37 (C_2″), 131.13/131.34 (C_6″), 132.63 (C_6′), 133.12 (C_1), 139.21/139.27 (C_3′), 140.98/141.13 (C_1′), 141.19/141.40 (C_2_), 146.21/146.71 (C_1″), 146.78/146.85 (C_4″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_16_BrNO_3_: 422.0188; found: 422.0182.
1-(2′-bromo-4-methoxy-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3b). Yield: 76%; Mp: 68 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.85–3.09 (m, 2H, CH_2_), 3.87/3.89 (s, 3H, CH_3_), 4.67–4.78 (m, 1H, CH), 6.69–8.08 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.15/44.89 (C_2_), 55.49–55.52 (C_a_), 71.78/72.32 (C_1_), 110.72/110.87 (C_3_), 113.27/113.64 (C_5_), 123.48/123.59 (C_2′), 124.42/124.79 (C_3″,5″), 127.59 (C_1_), 129.23/129.43 (C_5′), 130.33/130.36 (C_6), 130.52 (C_4′), 131.52/131.61 (C_2″/6″), 131.64/131.80 (C_6′), 132.63/133.15 (C_3′), 140.95/141.03 (C_1′), 142.53/143.01 (C_2), 146.22/146.75 (C_1″), 146.82/146.85 (C_4″), 159.88/160.08 (C_4_). HRMS (ESI): m/z [M ^+^Na]^+^ calcd for C_21_H_18_BrNO_4_:452.0294; found: 452.0294.
1-(2′-bromo-5-methyl-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3c). Yield: 62%; Mp: 67 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.38/3.40 (s, 3H, CH_3_), 2.85–3.12 (m, 2H, CH_2_), 4.65–4.73 (m, 1H, CH), 6.73–8.07 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 21.22/21.24 (CH_3_), 44.16/44.90 (C_2_), 71.52/72.02 (C_1_), 123.43/123.67 (C_2′), 123.56/124.02 (C_6), 125.57/125.72 (C_3″,5″), 127.49/127.53 (C_3), 129.22/129.43 (C_4_), 129.54/129.74 (C_5′), 129.84/130.36 (C_4′), 130.38/130.73 (C_2″,6″), 131.17/131.34 (C_6′), 132.56/133.02 (C_1_), 137.42/137.79 (C_3′), 138.06/138.39 (C_1′), 139.23 (C_2_), 141.30/141.34 (C_5_), 146.32/146.68 (C_1″), 146.76/147.01 (C_4″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_18_BrNO_3_: 436.0345; found: 436.0344.
1-(6-(2-bromophenyl)benzo[d][1,3]dioxol-5-yl)-2-(4-nitrophenyl)ethan-1-ol (3d). Yield: 58%; Mp: 168 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.82–3.07 (m, 2H, CH_2_), 4.55–4.64 (m, 1H, CH), 6.02–6.05 (m, 2H, H_2_), 6.49–8.08 (m, 10H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.35/44.81 (C_2_), 71.61/72.06 (C_1_), 101.57/101.60 (C_2_), 106.82/106.96 (C_7_), 109.23/110.09 (C_4_), 123.49/124.12 (C_2′), 123.64/124.49 (C_3″,5″), 127.54/127.67 (C_6_), 129.34/129.58 (C_5′), 130.33/130.37 (C_4′), 131.46/131.57 (C_2″,6″), 132.68/132.89 (C_6′), 133.11 (C_5_), 135.00/135.22 (C_3′), 140.92/140.93 (C_1′), 146.09 (C_1″), 146.75/146.81 (C_4″), 146.90/147.19 (C_3a_), 148.08/148.24 (C_7a_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_16_BrNO_5_: 466.0087; found: 466.0081.
1-(2′-bromo-5-methoxy-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3e). Yield: 49%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.85–3.11 (m, 2H, CH_2_), 4.61–4.68 (m, 1H, CH_k_), 3.82/3.83 (s, 3H, CH_3_), 6.56–8.07 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.27/44.96 (C_2_), 55.48/55.54 (C_a_), 71.29/71.78 (C_1_), 114.24/114.59 (C_4_), 114.76/115.21 (C_6_), 123.44/123.52 (C_2′), 123.58/123.87 (C_3), 127.05/127.22 (C_3″,5″), 127.49/127.57 (C_5′), 129.36/129.57 (C_4′), 130.40 (C_2″,6″), 131.07/131.20 (C_6′), 132.61/133.48 (C_3′), 133.07/133.27 (C_2_), 140.60 (C_1_), 141.06/141.07 (C_1′), 146.28/146.69 (C_1″), 146.78/146.97 (C_4″), 158.73/159.02 (C_5). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_18_BrNO_4_: 452.0294; found: 452.0290.
1-(2′-bromo-5-chloro-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3f). Yield: 69%; Mp: 116 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.82–3.09 (m, 2H, CH_2_), 4.65–4.74 (m, 1H, CH), 6.77–8.07 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.07/44.84 (C_2_), 71.17/71.71 (C_1_), 123.25/123.53 (C_2′), 123.63/123.75 (C_3″,5″), 127.37/127.47 (C_4_), 127.73 (C_6_), 128.91/129.12 (C_5′), 129.22/129.81 (C_3), 129.99/130.12 (C_4′), 130.34–130.39 (C_2″,6″), 130.96/131.18 (C_6′), 132.80/133.27 (C_3′), 133.32/133.61 (C_1_), 139.62/139.83 (C_5_), 139.81/140.16 (C_1′), 140.64 (C_2), 145.79/146.40 (C_1″), 146.80/146.88 (C_4″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_15_BrClNO_3_: 455.9795; found: 455.9796.
1-(2′-bromo-4-fluoro-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3g). Yield: 65%; Mp: 150 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.82–3.07 (m, 2H, CH_2_), 4.66–4.76 (m, 1H, HCH), 6.81–8.08 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.07/44.81 (C_2_), 71.50/72.04 (C_1_), 112.75 (d, J = 22.81 kHz)/112.86 (d, J = 22.53 Hz) (C_3_), 114.69 (d, J = 21.69 Hz)/115.10 (d, J = 21.65 Hz) (C_5_), 123.56/123.67 (C_3″,5″), 123.93/124.36 (C_2′), 127.72 (C_5′), 129.62/129.80 (C_4′), 130.32/130.34 (C_2″,6″), 131.11 (d, J = 8.03 Hz) (C_6), 131.35/131.57(C_6′), 132.12 (d, J = 7.99 Hz (C_6), 132.80/133.31 (C_3′), 134.85 (d, J = 3.58 Hz)/135.00 (d, J = 3.03 Hz) (C_1), 140.26/140.31 (C_1′), 143.69 (d, J = 6.63 Hz)/144.26 (d, J = 6.60 Hz) (C_2), 145.83/146.42 (C_1″), 146.84/146.91 (C_4″), 162.97 (d, J = 247.27 Hz)/163.18 (d, J = 247.73 Hz) (C_4_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_15_BrFNO_3_: 440.0094; found: 440.0095.
1-(2′-bromo-4-nitro-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3h). Yield: 78%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.84–3.09 (m, 2H, CH_2_), 4.76–4.86 (m, 1H, CH), 6.89–8.64 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.07/44.88 (C_2_), 71.20/71.78 (C_1_), 121.54 (C_5_), 122.47/122.70 (C_2′), 122.96/123.17 (C_3), 123.69/123.79 (C_3″,5″), 128.00 (C_5′), 130.29/130.39 (C_6_), 130.45/130.53 (C_4′), 130.71/130.79 (C_2″,6″), 131.75 (C_6′), 133.12/133.57 (C_3′), 139.17/139.22 (C_1′), 143.45/144.21 (C_1), 145.08/145.15 (C_2_), 145.38/145.87 (C_1″), 146.95/147.02 (C_4″), 148.31/148.56 (C_4_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_15_BrN_2_O_5_: 467.0039; found: 467.0038.
1-(2′-bromo-5-fluoro-[1,1′-biphenyl]-2-yl)-2-(4-nitrophenyl)ethan-1-ol (3i). Yield: 76%; Mp: 112 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.83–3.09 (m, 2H, CH_2_), 4.65–4.74 (m, 1H, CH), 6.75–8.08 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.27/44.99 (C_2_), 71.15/71.66 (C_1_), 115.78 (d, J = 19.1 Hz)/115.97 (d, J = 17.5 Hz) (C_4_), 116.18 (d, J = 20.0 Hz)/117.08 (d, J = 21.8 Hz) (C_6_), 123.31 (C_2′), 123.53 (C_3″,5″), 123.65 (C_2′), 127.69/127.73 (C_5′), 127.76 (d, J = 6.0 Hz)/127.89 (d, J = 8.3 Hz) (C_3_), 129.76/129.95 (C_4′), 130.37/130.39 (C_2″,6″), 130.91/131.11 (C_6′), 132.81/133.26 (C_3′), 136.97 (d, J = 3.1 Hz)/137.43 (d, J = 3.3 Hz) (C_2_), 140.01 (C_1′), 140.98 (d, J = 2.2 Hz)/141.06 (d, J = 2.2 Hz) (C_1), 145.92/146.54 (C_1″), 146.80/146.89 (C_4″), 160.60 (d, J = 27.1 Hz)/163.07 (d, J = 27.2 Hz) (C_5_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_15_BrFNO_3_: 440.0094; found: 440.0092.
3.4. General Procedure for the Synthesis of 1-(2′-Bromo-[1,1′-biphenyl]-2-yl)-2-(aryl)ethan-1-ol (4b–k)
The appropriate substituted benzylic chloride (1.3 equiv) in anhydrous DMF (10 mL) was added dropwise with a syringe under nitrogen to a sealed round-bottom flask containing 2′-bromo-[1,1′-biphenyl]-2-carbaldehyde (1a, 300 mg, 1 equiv) and TDAE (1.3 equiv). The solution was cooled to −20 °C, maintained at this temperature for 1 h, and then kept at room temperature for 2 h. The solution was then extracted with ethyl acetate (3 × 30 mL), and the extracts were washed with brine (3 × 50 mL), dried (Na_2_SO_4_), and evaporated under reduced pressure. Purification by silica gel chromatography (dichloromethane/cyclohexane: 7/3) gave the corresponding compounds 4b–k as “cis-substituted” and “trans-substituted” forms.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(2-nitrophenyl)ethan-1-ol (4b). Yield: 64%; Mp: 95 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.03–3.39 (m, 2H, CH_2_), 4.79–4.85 (m, 1H, CH), 6.76–7.80 (m, 12H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.24/41.26 (C_2_), 71.28/71.63 (C_1_), 123.60/124.17 (C_2′), 124.56/124.59 (C_3), 125.91/126.14 (C_6_), 127.45/127.50 (C_4″), 127.54 (C_6″), 127.91 (C_5″), 127.74/128.91 (C_4), 129.22/129.38 (C_5_), 130.26 (C_5′), 131.17/131.36 (C_4′), 132.44/132.53 (C_6′), 132.75/132.88 (C_1), 132.99/133.13 (C_3′), 133.32/133.35 (C_3″), 139.34/139.54 (C_1″), 141.18/141.21 (C_1′), 141.59 (C_2_), 150.19/150.67 (C_2″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_16_BrNO_3: 422.0188; found: 422.0182.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(6-nitrobenzo[d][1,3]dioxol-5-yl)ethan-1-ol (4c). Yield: 67%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.99–3.34 (m, 2H, CH_2_), 4.77–4.85 (m, 1H, CH_2_), 6.02–6.05 (m, 2H, H_2″), 6.26/6.35 (s, 1H, H_4″), 6.96–7.74 (m, 9H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 40.85/41.71 (C_2_), 71.32/71.73 (C_1_), 102.82/102.84 (C_2″), 105.53/105.57 (C_4″), 111.23/111.78 (C_2′), 123.63/124.15 (C_3), 125.90/126.07 (C_6_), 127.47/127.56 (C_4_), 127.93 (C_5_), 128.77/128.93 (C_5′), 129.30/129.34 (C_5″), 129.41/130.22 (C_7″), 130.31/130.40 (C_4′), 131.24/131.48 (C_6′), 132.51/133.15 (C_3′), 139.32/139.51 (C_1_), 141.17/141.21 (C_1′), 141.26/141.67 (C_2), 143.78/144.22 (C_6″), 146.71/146.74 (C_9″), 151.23/151.49 (C_8″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_16_BrNO_5: 466.0087; found: 466.0085.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(4,5-dimethoxy-2-nitrophenyl)ethan-1-ol (4d). Yield: 67%; Mp: 76 °C; ^1^H NMR (400 MHz, CDCl_3_, 25) δ (ppm) = 3.01–3.45 (m, 2H, H_2_), 3.68/3.69 (s, 3H, CH_3_), 3.89/3.90 (s, 3H, CH_3_), 4.84–4.87 (m, 1H, H_1_), 6.17/6.20 (s, 1H, H_6″), 6.66–7.77 (m, 9H, H_arom); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 40.36/41.83 (C_2_), 56.34 (C_a_), 56.43/56.46 (C_b_), 71.40/71.99 (C_1_), 107.92/107.97 (C_6″), 114.24/114.55 (C_2′), 123.73/124.15 (C_3_), 126.23/126.25 (C_6_), 127.28/127.32 (C_5_), 127.55/127.86 (C_4_), 128.00/128.15 (C_5′), 128.59/128.84 (C_1″), 129.15/129.31 (C_3″), 129.20/130.36 (C_4′), 131.44/131.53 (C_6′), 132.44/133.07 (C_1), 139.10/139.72 (C_3′), 141.11/141.26 (C_1′), 141.30/141.78 (C_2_), 142.14/142.69 (C_4″), 147.55/147.59 (C_2″), 152.48/152.72 (C_5″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_22_H_20_BrNO_5: 482.0400; found: 482.0399.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(3-methoxy-4-nitrophenyl)ethan-1-ol (4e). Yield: 80%; Mp: 76 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.80–3.06 (m, 2H, H_2_), 3.71/3.81 (s, 3H, CH_3_), 4.67–4.80 (m, 1H, H_1_), 6.32–7.81 (m, 11H, H_1_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.52/45.40 (C_2_), 56.13/56.43 (C_a_), 71.69/72.32(C_1_), 114.40/114.53 (C_2″), 131.26/121.29 (C_6″), 123.60/124.02 (C_2′), 125.60/125.65 (C_3), 125.74/125.86 (C_5″), 127.47/127.56 (C_6), 127.96 (C_4_), 128.69/128.92 (C_5_), 129.13/129.16 (C_5′), 129.42/130.19 (C_4′), 131.24/131.45 (C_6′), 132.44/133.00 (C_1), 137.87/137.90 (C_3′), 1138.99/139.30 (C_1′), 140.95/141.14 (C_4″), 141.16/141.39 (C_2), 145.85/146.77 (C_1″), 152.83/153.01 (C_3″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_18_BrNO_4_: 452.0294; found: 452.0297.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(3-methyl-4-nitrophenyl)ethan-1-ol (4f). Yield: 64%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.58 (s, 3H, CH_3_), 3.02–3.34 (m, 2H, CH_2_), 4.75–4.82 (m, 1H, CH), 6.88–7.76 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 40.17 (C_a_), 40.90/41.00 (C_2_), 71.15/71.34 (C_1_), 123.56/124.12 (C_2′), 125.80 (C_5″), 125.97/125.98 (C_3_), 127.49/127.56 (C_6_), 127.58/127.65 (C_6″), 128.07 (C_4), 128.73/128.96 (C_5_), 129.31/129.33 (C_5′), 129.50/130.32 (C_4′), 131.10/131.35 (C_2″), 132.53/132.83 (C_6′), 133.20 (C_1_), 135.21/135.61 (C_3″), 138.66/138.79 (C_3′), 139.24/139.38 (C_1′), 141.00/141.08 (C_2), 141.27 (C_1″), 148.37/148.79 (C_4″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_18_BrNO_3_: 436.0345; found: 436.0341.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(5-methyl-2-nitrophenyl)ethan-1-ol (4g). Yield: 64%; oil; ^1^H NMR (400 MHz, CDCl_3_, 25) δ (ppm) = 2.26/2.27 (2s, 3H, CH_3_), 3.02–3.34 (m, 2H, H_2_), 4.77–4.85 (m, 1H, H_1_), 6.83–7.75 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 21.32/21.39 (C_a_), 41.04/41.37 (C_2_), 71.45/71.83 (C_1_), 123.62/124.20 (C_2′), 124.74/124.77 (C_3″), 125.88/126.10 (C_3_), 127.29/127.46 (C_6_), 127.40/127.78 (C_4″), 128.03/128.08 (C_4), 128.63/128.82 (C_5_), 129.11/129.26 (C_5′), 129.14/130.22 (C_4′), 131.27/131.42 (C_6″), 132.39/133.11 (C_6′), 133.14/133.42 (C_1_), 133.56/133.90 (C_3′), 139.17/139.46 (C_1″), 141.24/141.45 (C_1′), 141.71 (C_2), 143.61/143.84 (C_5″), 147.78/148.19 (C_2″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_18_BrNO_3_: 436.0345; found: 436.0346.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(5-methoxy-2-nitrophenyl)ethan-1-ol (4h). Yield: 93%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.04–3.46 (m, 2H, CH_2_), 3.68/3.70 (s, 3H, CH_3_), 4.82–4.91 (m, 1H, CH), 6.28–7.90 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 40.85/40.96 (C_2_), 55.81/55.87 (C_a_), 71.22/71.81 (C_1_), 113.25/113.37 (C_4″), 116.93/117.32 (C_6″), 123.62/124.11 (C_2′), 126.06/126.17 (C_3), 127.33/127.34 (C_6_), 127.39/127.46 (C_3″), 127.82/128.62 (C_4), 128.83/129.31 (C_5_), 129.16/130.26 (C_5′), 131.34/131.39 (C_4′), 132.39/133.06 (C_6′), 136.21/136.56 (C_1), 139.17/139.62 (C_3′), 141.17/141.21 (C_1′), 141.24 (C_1″), 141.68 (C_2), 142.99/143.47 (C_2″), 162.57/162.76 (C_5″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_18_BrNO_4_: 452.0294; found: 452.0294.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(3-nitro-[1,1′-biphenyl]-4-yl)ethan-1-ol (4i). Yield: 75%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.07–3.42 (m, 2H, CH_2_), 4.83–4.89 (m, 1H, CH), 6.81–8.02 (m, 16H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 40.95/41.08 (C_2_), 71.35/71.58 (C_1_), 122.90 (C_2″), 123.62/124.18 (C_2′), 125.91/126.16 (C_3_), 127.03/127.07 (C_6_), 127.45/127.52 (C_4‴), 127.49/127.94 (C_4), 128.43/128.48 (C_2‴,6‴), 128.75/128.94 (C_5), 129.19/129.24 (C_5′), 129.22/129.38 (C_5″), 130.28 (C_3‴,5‴), 130.83/131.11 (C_4′), 131.18/131.40 (C_6′), 131.62/131.94 (C_1), 132.45/133.14 (C_3′), 133.36/133.80 (C_6″), 138.51/138.55 (C_4″), 139.38/139.53 (C_1″), 140.91/140.94 (C_1′), 141.19/141.22 (C_2), 141.63 (C_1‴), 150.48/150.95 (C_3″). HRMS (ESI): m/z [M+ Na]^+^ calcd for C_26_H_20_BrNO_3_: 498.0502; found: 498.0504.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(3-fluoro-4-nitrophenyl)ethan-1-ol (4j). Yield: 75%; oil; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.80–3.06 (m, 2H, CH_2_), 4.69–4.78 (m, 1H, CH), 6.67–7.90 (m, 11H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 43.96/44.74(C_2_), 71.22/71.82 (C_1_), 119.16 (d, J = 20.73 Hz)/119.25 (d, J = 20.42 Hz) (C_2″), 123.62/123.99 (C_2′), 125.55 (d, J = 3.63 Hz)/125.64 (d, J = 6.69 Hz) (C_5″), 125.66/125.68 (C_3), 125.81 (d, J = 2.33 Hz)/125.89 (d, J = 2.67 Hz) (C_6″), 127.62/127.65(C_6), 128.13 (C_4_), 128.77/129.00 (C_5_), 129.34 (C_5′), 129.46/129.58(C_4′), 130.28 (C_1′), 131.11/131.29 (C_6′), 132.73/133.14 (C_3′), 135.68/135.76(C_1), 139.12/139.15 (C_2′), 140.95 (d, J = 10.84 Hz)/141.17 (d, J = 14.51 Hz) (C_4″), 148.17 (d, J = 8.52 Hz)/148.85 (d, J = 8.27 Hz) (C_1″), 155.29 (d, J = 264.60 Hz)/155.36 (d, J = 264.50 Hz) (C_3″). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_15_BrFNO_3_: 440.0094; found: 440.0095.
1-(2′-bromo-[1,1′-biphenyl]-2-yl)-2-(4′-nitro-[1,1′-biphenyl]-4-yl)ethan-1-ol (4k). Yield: 82%; Mp: 138 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.86–3.12 (m, 2H, CH_2_), 4.71–4.81 (m, 1H, CH), 6.82–8.28 (m, 16H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 44.28/45.01 (C_2_), 72.01/72.53 (C_1_), 123.74/124.17 (C_2′), 124.21/124.24 (C_3), 125.73/125.86 (C_3‴,5‴), 127.30/127.38 (C_6), 127.46/127.51 (C_2″,6″), 127.61/127.65 (C_4), 127.72 (C_5_), 128.72/128.66 (C_5′), 129.16/129.19 (C_2‴,6‴), 129.37/130.13 (C_3″,5″), 130.29/130.31 (C_4′), 131.23/131.49 (C_6′), 132.51/133.05 (C_1), 136.83/136.97 (C_3′), 139.28/139.34 (C_4″), 139.51/140.07 (C_1′), 141.36/141.38 (C_1″), 141.42/141.95 (C_2_), 147.05 (C_1‴), 147.47/147.49 (C_4‴). HRMS (ESI): m/z [M+Na]^+^ calcd for C_26_H_20_BrNO_3_: 498.0502; found: 498.0504.
3.5. General Procedure for the Synthesis of 6H-Benzo[c]chromene (5a–s)
A mixture of 1-(2′-bromo-[1,1′-biaryl]-2-yl)-2-(aryl)ethan-1-ol (3a–i, 4b–k) (100 mg, 1 equiv), Pd(OAc)2 (0.04 equiv), PPh_3_ (0.25 equiv), and Cs_2_CO_3_ (3 equiv) was added to a Biotage microwave vial and the vial sealed, evacuated, and purged with N_2_ (×3). The toluene (4 mL) was added to the mixture under nitrogen. The reaction was then heated at 110 °C under microwave irradiation for 1.5 h. After cooling, H_2_O (50 mL) was added, and the solution was extracted with ethyl acetate (3 × 30 mL) and washed with brine (3 × 50 mL). The combined organic layers were dried over Na_2_SO_4_ and evaporated. The crude product was purified by column chromatography (silica gel, cyclohexane/CH_2_Cl_2_: 7/3).
6-(4-nitrobenzyl)-6H-benzo[c]chromene (5a). Yield: 88%; Mp: 113 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.93 (dd, J = 13.95, 4.80 Hz, 1H, CH_2_), 3.19 (dd, J = 13.95, 9.08 Hz, 1H, CH_2_), 5.31 (dd, J = 9.08 Hz, 4.80 1H, CH), 6.83 (dd, J = 8.07 Hz, 1H, H_arom_), 6.91 (d, J = 7.14 Hz, 1H, H_arom_), 7.07 (td, J = 7.50, 1.2 Hz, 1H, H_arom_), 7.24–7.28 (m, 4H, H_arom_), 7.39 (td, J = 7.66, 1.35 Hz, 1H, H_arom_), 7.75 (d, J = 7.76 Hz, 2H, H_arom_), 8.13 (d, J = 8.66 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.43 (C_a_), 78.00 (C_6_), 118.33 (C_4_), 122.22 (C_2_), 122.37 (C_10b_), 122.49 (C_3′,5′), 123.25 (C_7), 123.58 (C_10_), 125.23 (C_8_), 127.87 (C_9_), 128.81 (C_3_), 128.99 (C_2′,6′), 129.98 (C_1), 130.52 (C_10a_), 133.22 (C_6a_), 145.47 (C_1′), 146.92 (C_4′), 151.96 (C_4a_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_20_H_15_NO_3_: 340.0944; found: 340.0944.
8-methoxy-6-(4-nitrobenzyl)-6H-benzo[c]chromene (5b). Yield: 47%; Mp: 130 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.00 (dd, J = 13.99, 4.59 Hz, 1H, CH_2_), 3.26 (dd, J = 13.99, 9.16 Hz, 1H, CH_2_), 3.80 (s, 3H, CH_3_), 5.34 (dd, J = 9.16, 4.59 Hz, 1H, CH), 6.54 (d, J = 2.59 Hz, 1H, H_arom_), 6.89 (dd, J = 8.02, 1.24 Hz, 1H, H_arom_), 6.94 (dd, J = 8.62, 2.61 Hz, 1H, H_arom_), 7.05 (dt, J = 7.52, 1.25 Hz, 1H, H_arom_), 7.19 (dt, J = 7.52, 1.59 Hz, 1H, H_arom_), 7.30 (d, J = 8.68 Hz, 2H, H_arom_) 7.67–7.70 (m, 2H, H_arom_), 8.15 (d, J = 8.68 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.39 (C_a_), 55.55 (C_b_), 78.09 (C_6_), 110.61 (C_7_), 114.36 (C_9_), 118.21 (C_4_), 121.83 (C_2_), 122.32 (C_10b_), 122.39 (C_3′,5′), 122.61 (C_10a), 123.59 (C_3_), 124.02 (C_10_), 128.96 (C_2′,6′), 130.54 (C_1), 134.86 (C_6a_), 145.55 (C_1′), 146.93 (C_4′), 151.10 (C_4a_), 159.50 (C_8_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_21_H_17_NO_4_: 365.1496; found: 365.1499.
9-methyl-6-(4-nitrobenzyl)-6H-benzo[c]chromene (5c). Yield: 37%; Mp: 133 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.42 (s, 3H, CH_3_), 3.00 (dd, J = 13.94, 4.80 Hz, 1H, CH_2_), 3.26 (dd, J = 13.94, 8.98 Hz, 1H, CH), 5.37 (dd, J = 8.98, 4.80 Hz, 1H, CH), 6.89 (d, J = 7.59 Hz, 2H, H_arom_) 7.06–7.09 (m, 2H, H_arom_), 6.24–7.30 (m, 3H, H_arom_), 7.57 (s, 1H, H_arom_), 7.75 (dd, J = 7.77, 1.61 Hz, 1H, H_arom_), 8.14 (d, J = 8.69 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 21.65 (C_b_), 41.59 (C_a_), 77.94 (C_6_), 118.31 (C_4_), 122.28 (C_2_), 122.33 (C_10b_), 123.08 (C_3′,5′), 123.19 (C_3), 123.59 (C_10a_), 125.14 (C_7_), 128.64 (C_2′,6′), 128.81 (C_1), 129.82 (C_9_), 130.46 (C_10_), 130.55 (C_8_), 138.51 (C_6a_), 145.62 (C_1′), 146.91 (C_4′), 152.06 (C_4a_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_17_NO_3_: 354.1101; found: 354.1096.
6-(4-nitrobenzyl)-6H-[1,3]dioxolo[4′,5′:4,5]benzo[1,2-c]chromene (5d). Yield: 80%; Mp: 186 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.88 (dd, J = 13.98, 4.60 Hz, 1H, CH_2_), 3.26 (dd, J = 13.98, 9.10 Hz, 1H, CH_2_), 5.37 (dd, J = 9.10, 4.60 Hz, 1H, CH), 6.54 (s, 2H, CH_2_), 6.94 (dd, J = 8.11, 1.23 Hz, 1H, H_arom_), 7.10 (td, J = 7.57, 1.25 Hz, 1H, H_arom_), 7.30 (dd, J = 7.60, 1.59 Hz, 1H, H_arom_), 7.33 (s, 1H, H_arom_), 7.35 (d, J = 8.68 Hz, 2H, H_arom_) 7.63 (dd, J = 7.84, 1.56 Hz, 1H, H_arom_), 8.20 (d, J = 8.65 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.46 (C_a_), 78.05 (C_6_), 101.49 (C_9_), 103.08 (C_7_), 105.60 (C_11_), 118.15 (C_4_), 122.38 (C_2_), 122.41 (C_11b_), 122.75 (C_3′,5′), 123.38 (C_11a), 123.61 (C_3_), 127.34 (C_2′,6′), 129.23 (C_1), 130.48 (C_6a_), 145.45 (C_1′), 146.93 (C_4′), 147.50 (C_7a_), 148.42 (C_10a_), 151.14 (C_4a_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_15_NO_5_: 384.0842; found: 384.0840.
9-methoxy-6-(4-nitrobenzyl)-6H-benzo[c]chromene (5e). Yield: 55%; Mp: 123 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.00 (dd, J = 13.88, 5.00 Hz, 1H, CH_2_), 3.25 (dd, J = 13.88, 8.80 Hz, 1H, CH_2_), 3.88 (s, 3H, CH_3_), 5.37 (dd, J = 8.80, 5.00 Hz, 1H, CH), 6.80 (dd, J = 8.38, 2.50 Hz, 1H, H_arom_), 6.89–6.93 (m, 2H, H_arom_), 7.07 (td, J = 7.52, 1.24 Hz, 1H, H_arom_), 7.25–7.29 (m, 4H, H_arom_), 7.71 (dd, J = 7.76, 1.62 Hz, 1H, H_arom_), 8.13 (d, J = 8.70 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.73 (C_a_), 55.57 (C_b_), 77.77 (C_6_), 107.86 (C_8_), 113.40 (C_10_), 118.36 (C_4_), 122.16 (C_2_), 122.28 (C_10b_), 123.29 (C_7_), 123.58 (C_3′,5′), 125.75 (C_3), 126.42 (C_2′,6′), 130.10 (C_1), 130.30 (C_6a_), 130.56 (C_10a_), 145.57 (C_1′), 146.91 (C_4′), 152.13 (C_4a_), 160.11 (C_9_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_17_NO_4_: 370.1050; found: 370.1046.
9-chloro-6-(4-nitrobenzyl)-6H-benzo[c]chromene (5f). Yield: 77%; Mp: 138 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.00 (dd, J = 13.90, 5.00 Hz, 1H, CH_2_), 3.26 (dd, J = 13.90, 8.89 Hz, 1H, CH_2_), 5.38 (dd, J = 8.89, 5.00 Hz, 1H, CH), 6.90 (d, J = 8.13 Hz, 1H, CH), 6.91 (dd, J = 8.13, 1.22 Hz, 1H, CH), 7.09 (td, J = 7.53, 1.22 Hz, 1H, H_arom_), 7.23 (dd, J = 8.08, 2.04 Hz, 1H, H_arom_), 7.26–7.32 (m, 3H, H_arom_), 7.70 (dd, J = 7.79, 1.61 Hz, 1H, H_arom_), 7.72 (d, J = 2.04 Hz, 1H, H_arom_), 8.13–8.16 (m, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.29 (C_a_), 77.54 (C_6_), 118.47 (C_4_), 121.10 (C_2_), 122.58 (C_10b_), 122.68 (C_3′,5′), 123.40 (C_8), 123.68 (C_10_), 126.63 (C_3_), 127.74 (C_7_), 130.52 (C_2′,6′), 130.75 (C_1), 130.90 (C_10a_), 131.45 (C_9_), 134.83 (C_6a_), 144.99 (C_1′), 147.03 (C_4′), 152.02 (C_4a_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_20_H_14_ClNO_3_: 369.1000; found: 369.1000.
8-fluoro-6-(4-nitrobenzyl)-6H-benzo[c]chromene (5g). Yield: 80%; Mp: 132 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.02 (dd, J = 14.03, 4.57 Hz, 1H, CH_2_), 3.27 (dd, J = 14.03, 9.21 Hz, 1H, CH_2_), 5.36 (dd, J = 9.21, 4.57 Hz, 1H, CH), 6.75 (dd, J = 8.54, 2.63 Hz, 1H, H_arom_), 6.91 (dd, J = 8.09, 1.20 Hz, 1H, H_arom_), 7.06–7.13 (m, 2H, H_arom_), 7.24–7.32 (m, 3H, H_arom_), 7.68 (dd, J = 7.90, 1.73 Hz, 1H, H_arom_), 7.72 (dd, J = 8.85, 5.47 Hz, 1H, H_arom_), 8.15 (d, J = 8.68 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.09 (C_a_), 77.55 (C_6_), 112.18 (d, J = 22.50 Hz, C_7_), 115.89 (d, J = 21.77 Hz, C_9_), 118.38 (C_4_), 121.60 (C_10_), 122.59 (C_1_), 123.05 (C_10b_), 123.68 (C_3′,5′), 124.53(d, J = 8.17 Hz, C_10a), 125.34(d, J = 2.98 Hz, C_3_), 125.37 (C_2′,6′), 129.90 (C_1), 130.49 (C_1′), 135.41 (d, J = 7.22 Hz, C_6a), 145.04 (C_4′), 147.03 (C_4a), 151.46 (C_8_), 162.20 (d, J = 248.46 Hz, C_8_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_20_H_14_FNO_3_: 353.1296; found: 353.1296.
8-nitro-6-(4-nitrobenzyl)-6H-benzo[c]chromene (5h). Yield: 79%; Mp: 235 °C; ^1^H NMR (400 MHz, DMSO-d6) δ (ppm) = 3.14–3.22 (m, 2H, CH_2_), 5.80 (dd, J = 8.32, 5.5 Hz, 1H, CH), 6.91 (dd, J = 8.13, 1.17 Hz, 1H, H_arom_), 7.16 (td, J = 7.55, 1.19 Hz, 1H, H_arom_), 7.42 (ddd, J = 8.17, 7.32, 1.56 Hz, 1H, H_arom_), 7.52 (d, J = 8.75 Hz, 2H, H_arom_), 8.04 (dd, J = 7.88, 1.60 Hz, 1H, H_arom_), 8.15–8.20 (m, 3H, H_arom_), 8.26 (dd, J = 8.63, 2.40 Hz, 1H, H_arom_), 8.33 (dd, J = 2.38 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, DMSO-d6) δ (ppm) = 40. 15 (C_a_), 76.20 (C_6_), 118.32 (C_4_), 120.05 (C_2_), 121.15 (C_10b_), 122.66 (C_9_), 123.24 (C_3′,5′), 123.62 (C_7), 123.70 (C_3_), 124.85 (C_10_), 130.77 (C_2′,6′), 132.17 (C_1), 134.58 (C_10a_), 134.78 (C_6a_), 145.50 (C_1′), 146.30 (C_4′), 146.56 (C_8_), 152.20 (C_4a_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_20_H_14_N_2_O_5_: 380.1241; found: 380.1234.
9-fluoro-6-(4-nitrobenzyl)-6H-benzo[c]chromene (5i). Yield: 91%; Mp: 144 °C; ^1^H NMR (400 MHz, DMSO-d6) δ (ppm) = 3.00 (dd, J = 13.91, 5.00 Hz, 1H, CH_2_), 3.26 (dd, J = 13.91, 8.88 Hz, 1H, CH_2_), 5.39 (dd, J = 8.88, 5.00 Hz, 1H, CH), 6.92–6.96 (m, 3H, H_arom_), 7.09 (td, J = 7.56, 1.23 Hz, 1H, H_arom_), 7.25–7.32 (m, 2H, H_arom_), 7.42 (dd, J = 10.78, 1.70 Hz, 1H, H_arom_), 7.67 (dd, J = 7.78, 1.60 Hz, 1H, H_arom_), 8.15 (d, J = 8.67 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, DMSO-d6) δ (ppm) = 41.47 (C_a_), 77.57 (C_6_), 109.41 (d, J = 109.42 Hz, C_8_), 114.67 (d, J = 114.67 Hz, C_10_), 118.42 (C_4_), 121.37 (d, J = 2.27 Hz, C_10b_), 122.51 (C_2_), 123.46 (C_3′,5′), 123.64 (C_3), 126.96 (d, J = 8.60 Hz, C_7_), 128.89 (d, J = 2.93 Hz, C_10a_), 130.71 (C_1_), 130.52 (C_2′,6′), 131.31 (d, J = 8.54 Hz, C_6a), 145.13 (C_1′), 146.99 (C_4′), 151.96 (C_4a_), 163.23 (d, J = 245.71 Hz, C_9_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_20_H_14_FNO_3_: 353.1296; found: 353.1290.
6-(2-nitrobenzyl)-6H-benzo[c]chromene (5j). Yield: 79%; Mp: 154 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.26 (dd, J = 13.84, 9.66 Hz, 1H, CH_2_), 3.25 (dd, J = 13.84, 3.52 Hz, 1H, CH_2_), 5.64 (dd, J = 9.66, 3.52 Hz, 1H, CH), 6.93 (dd, J = 8.07, 1.26 Hz, 1H, H_arom_), 7.10 (td, J = 7.56, 1.26 Hz, 1H, H_arom_), 7.20 (dd, J = 7.57, 1.54 Hz, 1H, H_arom_), 7.27–7.34 (m, 3H, H_arom_), 7.38–7.45 (m, 2H, H_arom_), 7.53 (td, J = 7.56, 1.40 Hz, 1H, H_arom_), 7.77 (dd, J = 7.79, 1.19 Hz, 1H, H_arom_), 7.80 (dd, J = 7.77, 1.61 Hz, 1H, H_arom_), 8.04 (dd, J = 8.21, 1.41 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 38.84 (C_a_), 77.36 (C_6_), 118.48 (C_4_), 122.20 (C_2_), 122.26 (C_10b_), 122.32 (C_7_), 123.32 (C_10_), 125.16 (C_4′), 125.59 (C_6′), 127.97 (C_5′), 128.16 (C_8), 128.59 (C_9_), 128.67 (C_3_), 129.87 (C_1_), 132.95 (C_10a_), 133.22 (C_3′), 133.80 (C_1′), 134.03 (C_6a_), 149.40 (C_2′), 151.96 (C_4a). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_20_H_15_NO_3_: 335.1390; found: 335.1385.
6-((6-nitrobenzo[d][1,3]dioxol-5-yl)methyl)-6H-benzo[c]chromene (5k). Yield: 68%; Mp: 234 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.12 (dd, J = 13.88, 9.96 Hz, 1H, CH_2_), 3.36 (dd, J = 13.88, 2.96 Hz, 1H, CH_2_), 5.61 (dd, J = 9.99, 2.96 Hz, 1H, CH), 6.12 (d, J = 7.74 Hz, 1H, CH_2_), 6.57 (s, 1H, H_arom_), 6.95 (d, J = 8.07 Hz, 1H, H_arom_), 7.09 (t, J = 7.49 Hz, 1H, H_arom_), 7.30–7.41 (m, 4H, H_arom_), 7.60 (s, 1H, H_arom_), 7.78 (dd, J = 16.58, 7.72 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 39.52 (C_a_), 77.36 (C_6_), 103.03 (C_2′), 106.02 (C_4′), 112.40 (C_4_), 118.45 (C_2_), 122.17 (C_10b_), 122.30 (C_7_), 122.39 (C_10_), 123.39 (C_8_), 125.66 (C_9_), 128.27 (C_3_), 128.51 (C_5′), 128.68 (C_1), 129.95 (C_10a_), 130.78 (C_6a_), 133.86 (C_6′), 147.13 (C_7′a), 151.73 (C_4a_), 151.91 (C_3′a_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_21_H_15_NO_5_: 379.1288; found: 379.1286.
6-(4,5-dimethoxy-2-nitrobenzyl)-6H-benzo[c]chromene (5l). Yield: 87%; Mp: 170 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.16 (dd, J = 13.69, 9.88 Hz, 1H, CH_2_), 3.44 (dd, J = 13.7, 3.43 Hz, 1H, CH_2_), 3.85 (s, 3H, CH_3_), 3.96 (s, 3H, CH_3_), 5.65 (dd, J = 9.88, 3.43 Hz, 1H, CH), 6.45 (s, 1H, H_arom_), 6.907.40 (dd, J = 8.11, 1.23 Hz, 1H, H_arom_), 7.09 (td, J = 7.7, 1.0 Hz, 1H, H_arom_), 7.24–7.35 (m, 3H, H_arom_), 7.40 (td, J = 7.81, 1.90 Hz, 1H, H_arom_), 7.70 (s, 1H, H_arom_), 7.76 (d, J = 7.30 Hz, 1H, H_arom_), 7.81 (dd, J = 7.78, 1.62 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 39.61 (C_a_), 56.38 (C_c_), 56.46 (C_b_), 77.27 (C_6_), 108.38 (C_6′), 115.31 (C_4), 118.27 (C_2_), 122.15 (C_10b_), 122.23 (C_7_), 122.44 (C_10_), 123.45 (C_8_), 125.74 (C_9_), 128.19 (C_3_), 128.45 (C_1′), 128.52 (C_3′), 128.60 (C_1_), 129.64 (C_10a_), 133.95 (C_6a_), 141.28 (C_4′), 147.84 (C_2′), 152.02 (C_4a_), 152.86 (C_5′). HRMS (ESI): m/z [M+NH_4]^+^ calcd for C_22_H_19_NO_5_: 395.1601; found: 395.1596.
6-(3-methoxy-4-nitrobenzyl)-6H-benzo[c]chromene (5m). Yield: 71%; Mp: 84 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.97 (dd, J = 13.91, 4.94 Hz, 1H, CH_2_), 3.21 (dd, J = 13.91, 8.82 Hz, 1H, CH_2_), 3.87 (s, 3H, CH_3_), 5.40 (dd, J = 8.82, 4.94 Hz, 1H, CH), 6.75 (d, J = 1.74 Hz, 1H, H_arom_), 6.81 (dd, J = 8.29, 1.65 Hz, 1H, H_arom_), 6.92 (dd, J = 8.11, 1.24 Hz, 1H, H_arom_), 7.01 (dd, J = 8.11, 0.5 Hz, 1H, H_arom_), 7.07 (td, J = 7.52, 1.24 Hz, 1H, H_arom_), 7.24–7.30 (m, 2H, H_arom_), 7.40 (td, J = 7.72, 1.30 Hz, 1H, H_arom_), 7.76 (dd, J = 7.72, 1.55 Hz, 2H, H_arom_), 7.81 (d, J = 8.27 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.87 (C_a_), 56.54 (C_b_), 77.94 (C_6_), 114.93 (C_2′), 118.25 (C_4), 121.50 (C_2_), 122.20 (C_6′), 122.36 (C_10b), 122.47 (C_7_), 123.30 (C_5′), 125.36 (C_10), 125.97 (C_8_), 127.85 (C_9_), 128.81 (C_3_), 129.01 (C_1_), 129.90 (C_10a_), 133.19 (C_4′), 138.12 (C_6a), 145.28 (C_1′), 152.01 (C_3′), 153.07 (C_4a_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_21_H_17_NO_4_: 365.1496; found: 365.1495.
6-(3-methyl-4-nitrobenzyl)-6H-benzo[c]chromene (5n). Yield: 69%; Mp: 77 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.58 (s, 3H, CH_3_), 2.94 (dd, J = 13.96, 4.73 Hz, 1H, CH_2_), 3.20 (dd, J = 13.9, 9.11 Hz, 1H, CH_2_), 5.38 (dd, J = 9.11, 4.73 Hz, 1H, CH), 6.92 (dd, J = 8.10, 1.24 Hz, 1H, H_arom_), 6.99–7.03 (m, 1H, H_arom_), 7.05–7.11 (m, 3H, H_arom_), 7.25–7.30 (m, 2H, H_arom_), 7.40 (td, J = 7.62, 1.24 Hz, 1H, H_arom_), 7.76 (td, J = 7.77, 1.41 Hz, 2H, H_arom_), 7.92 (d, J = 8.16 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 20.82 (C_b_), 41.27 (C_a_), 78.07 (C_6_), 118.34 (C_4_), 122.26 (C_2_), 122.32 (C_10b_), 122.45 (C_5′), 123.25 (C_7), 124.94 (C_10_), 125.27 (C_6′), 127.84 (C_8), 128.12 (C_9_), 128.77 (C_3_), 128.99 (C_1_), 129.94 (C_2′), 133.38 (C_10a), 133.86 (C_3′), 134.06 (C_6a), 143.68 (C_1′), 147.78 (C_4′), 152.02 (C_4a_). HRMS (ESI): m/z [M+Na]^+^ calcd for C_21_H_17_NO_3_: 349.1547; found: 349.1554.
6-(5-methyl-2-nitrobenzyl)-6H-benzo[c]chromene (5o). Yield: 66%; Mp: 187 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.40 (s, 3H, CH_3_), 3.20 (dd, J = 13.71, 9.90 Hz, 1H, CH_2_), 3.36 (dd, J = 13.7, 3.28 Hz, 1H, CH_2_), 5.63 (dd, J = 9.90, 3.28 Hz, 1H, CH), 6.91 (dd, J = 8.09, 1.23 Hz, 1H, H_arom_), 6.96 (d, J = 1.95 Hz, 1H, H_arom_), 7.10 (td, J = 7.50, 1.24 Hz, 1H, H_arom_), 7.21 (ddd, J = 8.35, 1.84, 0.78 Hz, 1H, H_arom_), 7.28–7.34 (m, 3H, H_arom_), 7.40 (td, J = 7.81, 1.83 Hz, 1H, H_arom_), 7.76 (dd, J = 7.78, 1.17 Hz, 1H, H_arom_), 7.81 (dd, J = 7.76, 1.60 Hz, 1H, H_arom_), 7.98 (d, J = 8.33 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 21.50 (C_b_), 39.10 (C_a_), 77.39 (C_6_), 118.43 (C_4_), 122.17 (C_2_), 122.22 (C_10b_), 122.41 (C_3′), 123.36 (C_7), 125.43 (C_10_), 125.65 (C_4′), 128.16 (C_8), 128.55 (C_9_), 128.63 (C_3_), 129.81 (C_1_), 133.34 (C_6′), 133.95 (C_1′), 134.73 (C_6a_), 144.16 (C_5′), 146.99 (C_2′), 152.03 (C_4a_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_21_H_17_NO_3_: 349.1547; found: 349.1550.
6-(5-methoxy-2-nitrobenzyl)-6H-benzo[c]chromene (5p). Yield: 49%; Mp: 170 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.19 (dd, J = 13.62, 10.0 Hz, 1H, CH_2_), 3.45 (dd, J = 13.6, 3.12 Hz, 1H, CH_2_), 3.84 (s, 3H, CH_3_), 5.66 (dd, J = 10.0, 3.10 Hz, 1H, CH), 6.58 (d, J = 2.80 Hz, 1H, H_arom_), 6.88 (dd, J = 9.16, 2.80 Hz, 1H, H_arom_), 6.94 (dd, J = 8.02, 1.27 Hz, 1H, H_arom_), 7.09 (td, J = 7.52, 1.23 Hz, 1H, H_arom_), 7.26–7.32 (m, 1H, H_arom_), 7.33 (d, J = 3.89 Hz, 2H, H_arom_), 7.40 (dt, J = 7.77, 4.32 Hz, 1H, H_arom_), 7.77 (d, J = 7.71 Hz, 1H, H_arom_), 7.81 (dd, J = 7.79, 1.60 Hz, 1H, H_arom_), 8.16 (d, J = 9.13 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 39.81 (C_a_), 55.94 (C_b_), 77.21 (C_6_), 113.43 (C_4′), 118.43 (C_6′), 118.46 (C_4_), 122.16 (C_2_), 122.27 (C_10b_), 122.45 (C_7_), 123.41 (C_10_), 125.70 (C_3′), 128.07 (C_8), 128.23 (C_9_), 128.51 (C_3_), 128.64 (C_1_), 129.79 (C_10a_), 133.97 (C_1′), 136.58 (C_6a), 142.15 (C_2′), 151.96 (C_4a), 163.06 (C_5′). HRMS (ESI): m/z [M+NH_4]^+^ calcd for C_21_H_17_NO_4_: 365.1496; found: 365.1497.
6-((3-nitro-[1,1′-biphenyl]-4-yl)methyl)-6H-benzo[c]chromene (5q). Yield: 75%; Mp: 140 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 3.30 (dd, J = 13.88, 9.63 Hz, 1H, CH_2_), 3.38 (dd, J = 13.88, 3.59 Hz, 1H, CH_2_), 5.68 (dd, J = 9.63, 3.59 Hz, 1H, CH), 6.97 (dd, J = 8.02, 1.21 Hz, 1H, H_arom_), 7.11 (dt, J = 7.56, 1.27 Hz, 1H, H_arom_), 7.26 (t, J = 4.00 Hz, 1H, H_arom_), 7.28–7.36 (m, 3H, H_arom_), 7.39–7.46 (m, 2H, H_arom_), 7.48–7.52 (m, 2H, H_arom_), 7.60–7.66 (m, 2H, H_arom_), 7.74–7.80 (m, 2H, H_arom_), 7.82 (dd, J = 7.78, 1.60 Hz, 1H, H_arom_), 8.27 (d, J = 1.94 Hz, 1H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 39.68 (C_a_), 77.44 (C_6_), 118.50 (C_4_), 122.22 (C_2_), 122.28 (C_2′), 122.35 (C_10b), 123.35 (C_7_), 123.50 (C_10_), 125.63 (C_4″), 127.17 (C_8), 128.21 (C_2″,6″), 128.56 (C_9), 128.61 (C_3_), 128.70 (C_5′), 129.28 (C_3″,5″), 129.90 (C_1_), 131.30 (C_10a_), 131.85 (C_6′), 133.83 (C_4′), 134.49 (C_1′), 138.57 (C_6a), 141.41 (C_1″), 149.72 (C_3′), 151.98 (C_4a_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_26_H_19_NO_3_: 411.1703; found: 411.1707.
6-(3-fluoro-4-nitrobenzyl)-6H-benzo[c]chromene (5r). Yield: 71%; Mp: 91 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.99 (dd, J = 14.07, 4.47 Hz, 1H, CH_2_), 3.25 (dd, J = 14.1, 9.2 Hz, 1H, CH_2_), 5.40 (dd, J = 9.21, 4.47 Hz, 1H, CH), 6.92 (dd, J = 8.10, 1.24 Hz, 1H, H_arom_), 7.02–7.12 (m, 4H, H_arom_), 7.26–7.33 (m, 2H, H_arom_), 7.42 (td, J = 7.66, 1.36 Hz, 1H, H_arom_), 7.76 (dt, J = 7.75, 1.46 Hz, 2H, H_arom_), 7.99 (dd, J = 8.73, 7.69 Hz, 1H, H_arom_).
^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.31 (C_a_), 77.63 (C_6_), 118.31 (C_4_), 119.43 (d, J = 20.9 Hz) (C_2′), 122.16 (C_2), 122.56 (d, J = 5.0 Hz) (C_7_), 123.32 (C_8_), 125.13 (C_9_), 125.78 (d, J = 3.8 Hz) (C_5′), 126.09 (d, J = 2.6 Hz) (C_6′), 128.02 (C_10_), 129.01 (d, J = 2.2 Hz) (C_1_), 130.11 (C_10a_), 132.94 (C_6a_), 147.36 (d, J = 8.4 Hz) (C_4′), 151.80 (C_1′), 155.54 (d, J = 264.9 Hz) (C_3′). HRMS (ESI): m/z [M+NH_4]^+^ calcd for C_20_H_14_FNO_3_: 353.1296; found: 353.1300.
6-((4′-nitro-[1,1′-biphenyl]-4-yl)methyl)-6H-benzo[c]chromene (5s). Yield: 70%; Mp: 157 °C; ^1^H NMR (400 MHz, CDCl_3_) δ (ppm) = 2.96 (dd, J = 14.01, 4.88 Hz, 1H, CH_2_), 3.25 (dd, J = 14.0, 9.13 Hz, 1H, CH_2_), 5.41 (dd, J = 9.1, 4.9 Hz, 1H, CH), 6.97 (dd, J = 8.11, 1.22 Hz, 1H, H_arom_), 7.03 (d, J = 7.52 kHz, 1H, H_arom_), 7.09 (td, J = 7.51, 1.24 Hz, 1H, H_arom_), 7.24–7.32 (m, 4H, H_arom_), 7.40 (dt, J = 7.66, 1.29 Hz, 1H, H_arom_), 7.57 (d, J = 8.25 Hz, 2H, H_arom_), 7.69–7.82 (m, 4H, H_arom_), 8.29 (d, J = 8.83 Hz, 2H, H_arom_); ^13^C NMR (100 MHz, CDCl_3_) δ (ppm) = 41.30 (C_a_), 78.71 (C_6_), 118.50 (C_4_), 122.17 (C_2_), 122.41 (C_10b_), 122.43 (C_7_), 123.23 (C_3″,5″), 124.27 (C_10), 125.42 (C_2′,6′), 127.41 (C_8), 127.76 (C_9_), 128.59 (C_2″,6″), 129.02 (C_3′,5′), 129.86 (C_1_), 130.50 (C_10a_), 133.91 (C_4′), 137.06 (C_1′), 138.88 (C_6a_), 147.12 (C_4″), 147.57 (C_1″), 152.25 (C_4a_). HRMS (ESI): m/z [M+NH_4_]^+^ calcd for C_26_H_19_NO_3_: 411.1703; found: 411.1708.
4. Conclusions
Two new series of 1-(2′-bromo-[1,1′-biaryl]-2-yl)-2-(aryl)ethan-1-ols were synthesized using the TDAE strategy. This method employs TDAE (tetrakis(dimethylamino)ethylene) as a metal-free organic reductant for the initial formation of 1-(2′-bromo-[1,1′-biaryl]-2-yl)-2-(aryl)ethan-1-ols, avoiding the use of stoichiometric metals at this stage. However, the subsequent cyclization step to synthesize 6H-benzo[c]chromenes requires a palladium catalyst (Pd(OAc)2/PPh_3_), introducing a metal-dependent process in the overall synthetic route. In the presence of TDAE, the reactions of 2′-bromo-biaryl-2-carbaldehydes with 4-nitrobenzyl chloride or of substituted benzyl chlorides with 2′-bromo-[1,1′-biphenyl]-2-carbaldehyde gave the corresponding alcohol in 62–93% yields. The obtained alcohol derivatives thus formed were good candidates for the synthesis of 6H-benzo[c]chromenes via an intramolecular cyclization in the presence of Pd(OAc)2/PPh_3_ and Cs_2_CO_3_ at 110 °C under microwave irradiation for 1.5 h. Regarding the two isomers of compounds 3 and 4 (the “cis-substituted” and “trans-substituted” forms), we demonstrated their interconversion (thermodynamic barrier) under the effect of heat during evaporation. The final step yields compounds 5a–s as racemates.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Mahesh M. Murphy J.A. Le Strat F. Wessel H.P. Reduction of arenediazonium salts by tetrakis (dimethylamino) ethylene (TDAE): Efficient formation of products derived from aryl radicals Beilstein J. Org. Chem.20095110.3762/bjoc.5.119259337 PMC 2649425 · doi ↗ · pubmed ↗
- 2Murphy J.A. Khan T.A. Zhou S. Thomson D.W. Schoenebeck F. Mahesh M. Park S.R. Tuttle T. Berlouis L.E.A. Generation of aryl anions by double electron transfer to aryl iodides from a neutral ground-state organic super electron donor (SED)Angew. Chem. Int. Ed.2007465178518310.1002/anie.20070055417546715 · doi ↗ · pubmed ↗
- 3Murphy J.A. Khan T.A. Zhou S. Thomson D.W. Mahesh M. Highly efficient reduction of unactivated aryl and alkyl iodides by a ground-state neutral organic electron donor Angew. Chem.2005441356136010.1002/anie.20046203815674987 · doi ↗ · pubmed ↗
- 4Pooput C. Medebielle M. Dolbier W.R. Nucleophilic perfluoroalkylation of aldehydes, ketones, imines, disulfides, and diselenides J. Org. Chem.2006713564356810.1021/jo 060250 j 16626142 · doi ↗ · pubmed ↗
- 5Pooput C. Medebielle M. Dolbier W.R. A new and efficient method for the synthesis of trifluoromethylthio-and selenoethers Org. Lett.2004630130310.1021/ol 036303 q 14723553 · doi ↗ · pubmed ↗
- 6Medebielle M. Kato K. Dolbier W.R. Fluorinated hydrazones. Part 1: Reductive coupling reactions of chlorodifluoroacetylated dialkylhydrazones using tetrakis (dimethylamino) ethylene (TDAE)Tetrahedron Lett.2003447871787310.1016/j.tetlet.2003.09.020 · doi ↗
- 7Takechi N. Ait-Mohand S. Medebielle M. Dolbier W.R. Nucleophilic trifluoromethylation of acyl chlorides using the trifluoromethyl iodide/TDAE reagent Tetrahedron Lett.2002434317431910.1016/S 0040-4039(02)00800-6 · doi ↗
- 8Takechi N. Ait-Mohand S. Medebielle M. Dolbier W.R. Novel nucleophilic trifluoromethylation of vicinal diol cyclic sulfates Org. Lett.200244671467210.1021/ol 027037412489957 · doi ↗ · pubmed ↗
